This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Wilex Ag. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Pia Klöpfer: Innovator in Cancer Diagnosis and Treatment
Introduction
Pia Klöpfer is a notable inventor based in Munich, Germany. She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of cancer diseases. Her innovative work focuses on the quantification of carbonic anhydrase IX (CAIX) expression, which plays a crucial role in cancer classification.
Latest Patents
Pia Klöpfer holds a patent for her invention titled "Classifying a cancer disease using CAIX expression." This invention relates to a carbonic anhydrase IX targeting compound used in cancer treatment. The method involves quantifying CAIX expression and determining a CAIX score based on this expression. This innovative approach aids in diagnosing, predicting, and classifying cancer diseases effectively.
Career Highlights
Throughout her career, Pia has worked with prominent companies in the pharmaceutical industry, including Wilex AG and Heidelberg Pharma AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas in cancer treatment and diagnosis.
Collaborations
Pia has collaborated with esteemed colleagues such as Olaf G Wilhelm and Paul Bevan. These partnerships have contributed to her success and the advancement of her research in cancer therapies.
Conclusion
Pia Klöpfer is a pioneering inventor whose work in cancer diagnosis and treatment has the potential to make a significant impact in the medical field. Her innovative approach to quantifying CAIX expression represents a valuable advancement in cancer research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile